Skip to content

EBIT at other companies

Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$141.77M+41.3%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$34.64M-25.8%
ALN
Alnylam PharmaceuticalsALNY
$268.64M+1,386%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$41.42M+89.6%
Viatris logo
ViatrisVTRS
Amgen logo
AmgenAMGN

Other financials

Income statement

See full
Revenue$237.5M+20.5%
Gross profit$143.9M+16.0%
Operating income$38.9M+48.5%
Net income$29.5M+88.1%
EPS (diluted)$1.28+85.5%

Balance sheet

See full
Cash & equivalents$311.2M+108%
Total debt$305.3M-3.5%
Total equity$562.3M+34.3%
Total assets$1.4B+10.0%

Cash flow

See full
Operating cash flow$58.4M+66.8%
CapEx$6.1M+146%
Free cash flow$52.3M+60.8%

Valuation

See full
Market cap$1.89B+18.3%
Enterprise value$1.88B+5.8%
P/E20.5×
P/S-0.3×

Profitability

See full
Gross margin60.8%+1.5pp
Operating margin13.4%
Net margin10%+8.1pp
FCF margin20.7%+10.8pp

Returns & leverage

See full
Return on equity18.8%+15.6pp
Debt / equity0.5×-0.2×
Current ratio3.1×+0.5×

Where this comes from

Calculated from ANI Pharmaceuticals’s reported figures.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ANI Pharmaceuticals's EBIT?
ANI Pharmaceuticals (ANIP) reported EBIT of $38.89M in Q1 2026.
How has ANI Pharmaceuticals's EBIT changed year-over-year?
ANI Pharmaceuticals's EBIT increased by 48.5% year-over-year, from $26.19M to $38.89M.
What is the long-term trend for ANI Pharmaceuticals's EBIT?
Over 4 years (2021 to 2025), ANI Pharmaceuticals's EBIT has grown at a 29.3% compound annual growth rate (CAGR), from -$39.79M to $111.09M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.